Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. It has now been 100 years since the first patient with diabetes received an injection of ...

Managing diabetes is expensive, and not just because of insulin or doctor visits. Daily supplies, monitoring equipment, ...

The rising price of insulin has become one of the most talked about issues across the pharma industry. Ben Hargreaves explains how Eli Lilly decided to cap its insulin price, why it has decided to ...

among other older insulin brands in India. Human Mixtard alone is a Rs 800 crore brand for Novo Nordisk in India, despite it being under price control. Besides Human Mixtard, the phase-out could ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Many Medicare recipients are benefiting from changes that make prescriptions more affordable. But you can still make other ...

Several April releases seem to signal some basis for optimism for stakeholders in Medicare Advantage and Part D, though with sufficient undertones ...

Artificial sweeteners are found in thousands of food products, and especially soft drinks. And while you might think they are ...

Novo Nordisk, the maker of Wegovy, announced exclusively on " Good Morning America " Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions ...

Australian political and media history: the nation’s first truly social media-driven election.For the first time, Millennials ...

State Sen. Darrin Camilleri, D-Trenton, who sponsored the bills, said there’s no one-size fits all solution. The “common ...